Bioventus Inc

BVSNASDAQ · USD
10.66USD0.00 (-1.85%)
859

Bioventus Inc (BVS) Covered Calls

Bioventus Inc trades in the Medical Devices industry with an IV Rank of 93.25%, high versus the past year. BVS's highest covered call setup is the $12.50 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 15.10% out of the money with 36 days to expiration, a 15.56% return until expiration, and a 157.78% theoretical annualized return. Across the setups shown, annualized returns run from 36.65% to 157.78% at strikes between $12.50 and $12.50, with 36 to 155 days to expiration, as of Nov 12, 2026.

Read more

Running BVS covered calls helps you generate income from Bioventus Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best BVS covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If BVS stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling BVS covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given BVS covered call is worth writing.

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement.

2026-12-183612.5015.100.050.75169.0015.56157.78-0.46+0.3050.70
2027-01-156412.5015.100.301.05194.0017.86101.88-2.76+0.37790.75
2027-04-1615512.5015.100.052.25169.0015.5636.65-0.46+0.45662.20

As of Nov 12, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank93.25% High
  • Market cap (M$)898
  • 52 weeks high-32.91%
  • 52 weeks low64.76%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$16.60
    55.72% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-02
  • P/E13.12
  • Future P/E12.01
  • EPS (ttm)0.81
  • EPS growth next 5 years15.01%

As of Nov 13, 2026